AMH

Anti-Müllerian Hormone

Hormones

What is Anti-Müllerian Hormone?

Anti-Müllerian hormone (AMH) is a glycoprotein hormone belonging to the transforming growth factor-beta (TGF-β) superfamily. In women, AMH is produced by granulosa cells of small antral and pre-antral follicles in the ovaries. It serves as one of the best available biomarkers of ovarian reserve—the remaining pool of eggs available for potential fertilization. AMH levels correlate with the number of antral follicles visible on ultrasound and reflect the quantity (though not the quality) of a woman's remaining oocytes.

Unlike FSH and estradiol, AMH levels remain relatively stable throughout the menstrual cycle and can be measured at any time, making it a convenient clinical test. AMH levels decline steadily with age as the follicular pool diminishes, becoming undetectable at menopause. In reproductive medicine, AMH is widely used to predict ovarian response to stimulation during IVF, counsel patients on fertility timelines, and evaluate conditions like polycystic ovary syndrome (PCOS) where AMH is characteristically elevated.

Why It Matters

AMH is the most reliable and practical blood test for assessing ovarian reserve. It helps women and their physicians make informed decisions about family planning, fertility preservation, and the likelihood of success with assisted reproductive technologies. Low AMH indicates diminished ovarian reserve and predicts poor response to IVF stimulation, while high AMH may suggest PCOS and predicts risk of ovarian hyperstimulation. AMH is also used in pediatric endocrinology to evaluate disorders of sex development and in oncology to assess residual ovarian function after chemotherapy.

Normal Reference Ranges

GroupRangeUnit
Women (25–30 years)1.0–5.0ng/mL
Women (31–35 years)0.7–3.5ng/mL
Women (36–40 years)0.3–2.0ng/mL
Women (41–45 years)0.1–1.0ng/mL
Men1.4–15.3ng/mL

Reference ranges may vary by laboratory. Always compare results to the ranges provided by your testing facility.

What High AMH Levels Mean

Common Causes

  • Polycystic ovary syndrome (PCOS)—levels often 2–4× age-expected
  • Granulosa cell ovarian tumors
  • Ovarian hyperstimulation during fertility treatment
  • Normal variation in young women with large follicular pools

Possible Symptoms

  • Irregular or absent menstrual periods (in PCOS)
  • Signs of hyperandrogenism (acne, hirsutism) in PCOS
  • Ovarian hyperstimulation syndrome (abdominal pain, bloating, nausea) during IVF
  • Often asymptomatic when elevated in isolation

What to do: Elevated AMH in the setting of irregular periods and hyperandrogenism supports a diagnosis of PCOS. AMH >5 ng/mL in a young woman with oligomenorrhea is highly suggestive of PCOS, though AMH is not yet part of the formal Rotterdam diagnostic criteria. During IVF, high AMH predicts vigorous response to gonadotropin stimulation, and doses should be reduced to prevent ovarian hyperstimulation syndrome (OHSS). A GnRH agonist trigger instead of hCG can reduce OHSS risk. Very high AMH with a pelvic mass should prompt evaluation for granulosa cell tumor.

What Low AMH Levels Mean

Common Causes

  • Diminished ovarian reserve (age-related or premature)
  • Premature ovarian insufficiency (POI)
  • Prior ovarian surgery (cystectomy, oophorectomy)
  • Chemotherapy or pelvic radiation
  • Endometriosis (particularly ovarian endometriomas)
  • Smoking
  • Approaching menopause

Possible Symptoms

  • Shortened menstrual cycles
  • Difficulty conceiving
  • Poor response to IVF stimulation
  • Hot flashes and night sweats (if approaching menopause or POI)
  • Often no symptoms—low AMH can precede cycle changes by years

What to do: Low AMH indicates reduced ovarian reserve but does not preclude natural conception—AMH reflects egg quantity, not quality. Women with low AMH who desire future pregnancy should consult a reproductive endocrinologist promptly, as reserve continues to decline. Fertility preservation (egg or embryo freezing) may be discussed. During IVF, higher gonadotropin doses or alternative protocols (mini-IVF, natural cycle IVF) may be used. FSH and antral follicle count on ultrasound provide complementary information. Importantly, AMH should not be used as a contraceptive—women with low AMH can still ovulate and conceive spontaneously.

When Is AMH Testing Recommended?

  • When assessing ovarian reserve before fertility treatment or egg freezing
  • When counseling women about family planning timelines
  • When evaluating suspected PCOS
  • When assessing residual ovarian function after chemotherapy

Frequently Asked Questions

AMH is a marker of ovarian reserve (egg quantity), not fertility per se. A low AMH means fewer remaining eggs, which can reduce the window of opportunity for conception and predict lower success with IVF, but it does not mean you cannot conceive naturally. Studies show that women with low AMH who are otherwise ovulatory can have similar natural conception rates as women with normal AMH in the short term. Conversely, a normal or high AMH does not guarantee pregnancy—egg quality (which correlates more with age), tubal patency, sperm quality, and many other factors are equally important. AMH is best used as one piece of the fertility puzzle, not as a standalone fertility predictor.
Yes, one of AMH's advantages is that it can be drawn at any point in the menstrual cycle. Unlike FSH and estradiol (which must be tested on cycle day 2–4 for accurate interpretation), AMH levels show minimal fluctuation across the cycle. There may be slight variation (some studies show marginally lower AMH at ovulation), but these differences are not clinically significant. AMH can also be tested while on oral contraceptives, though hormonal contraception can suppress AMH by 20–30%—this should be considered when interpreting borderline-low results in women on the pill.
In PCOS, the ovaries contain an excess of small antral follicles (the polycystic morphology seen on ultrasound). Since AMH is produced by the granulosa cells of these small follicles, having 2–3 times the normal number of antral follicles results in proportionally elevated AMH. Additionally, each PCOS follicle may produce more AMH per follicle than normal, possibly due to dysregulated follicular development where follicles arrest at the small antral stage rather than progressing to ovulation. AMH levels >5 ng/mL have been proposed as a diagnostic criterion for PCOS and may eventually replace ultrasound follicle counting in the diagnostic criteria, as it is more reproducible and accessible.

Related Biomarkers

FSHFollicle-Stimulating HormoneLHLuteinizing HormoneE2Estradiol

Want your AMH levels analyzed?

Upload your lab results for an instant AI-powered breakdown of all your biomarkers.

Upload Lab Results →

Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Reference ranges may vary between laboratories. Always consult your healthcare provider for interpretation of your specific test results.

Disclaimer: SymptomGPT is not a medical diagnosis tool and does not provide medical advice. Always consult a qualified healthcare professional. If you are experiencing a medical emergency, call 911 immediately.